96
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer

, , , , , & show all
Pages 5715-5727 | Published online: 09 Sep 2015

References

  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin20146492924399786
  • SalinasCATsodikovAIshak-HowardMProstate cancer in young men: an important clinical entityNat Rev Urol20141131732324818853
  • GehrigSSamiHOgrisMGene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranosticsTher Deliv201451275129625531929
  • VaderGLensSMThe aurora kinase family in cell division and cancerBiochim Biophys Acta20081786607218662747
  • Bar-ShiraAPinthusJHRozovskyUMultiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograftCancer Res2002626803680712460888
  • LeeECFrolovALiRAyalaGGreenbergNMTargeting aurora kinases for the treatment of prostate cancerCancer Res2006664996500216707419
  • QuYZhangLMaoMEffects of DNAzymes targeting aurora kinase A on the growth of human prostate cancerCancer Gene Ther20081551752518404163
  • KatayamaHSasaiKKawaiHPhosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53Nat Genet200436556214702041
  • CheungCHSarvagallaSLeeJYHuangYCCoumarMSAurora kinase inhibitor patents and agents in clinical testing: an update (2011–2013)Expert Opin Ther Pat2014241021103824965505
  • OhYKParkTGsiRNA delivery systems for cancer treatmentAdv Drug Deliv Rev20096185086219422869
  • PereiraDMRodriguesPMBorralhoPMRodriguesCMDelivering the promise of miRNA cancer therapeuticsDrug Discov Today20131828228923064097
  • FarooqiAARehmanZUMuntaneJAntisense therapeutics in oncology: current statusOnco Targets Ther201472035204225395862
  • IsakaYDNAzymes as potential therapeutic moleculesCurr Opin Mol Ther2007913213617458166
  • TanMLChoongPFDassCRDNAzyme delivery systems: getting past first baseExpert Opin Drug Deliv2009612713819239385
  • SclhubertSKurreckJRibozyme and deoxyribozyme strategies for medical applicationsCurr Drug Targets2004566768115578948
  • KarnatiHKYalagalaRSUndiRPasupuletiSRGuttiRKTherapeutic potential of siRNA and DNAzymes in cancerTumour Biol2014359505952125149153
  • PunSHTackFBellocqNCTargeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferring-modified, cyclodextrin-based particlesCancer Biol Ther2004364165015136766
  • TackFNoppeMVan DijckADelivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approachPharmazie20086322122518444511
  • ChanCWKhachigianLMDNAzyme delivery approaches in biological settingsCurr Med Chem2013203448345523745555
  • El-AneedAAn overview of current delivery systems in cancer gene therapyJ Control Release20049411414684267
  • TianHChenJChenXNanoparticles for gene deliverySmall201392034204423630123
  • GodbeyWTWuKKMikosAGTracking the intracellular path of poly(ethylenimine)/DNA complexes for gene deliveryProc Natl Acad Sci U S A1999965177518110220439
  • TianHLinLChenJChenXParkTGMaruyamaARGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriersJ Control Release2011155475321281679
  • JonesCHChenCKRavikrishnanARaneSPfeiferBAOvercoming nonviral gene delivery barriers: perspective and futureMol Pharm2013104082409824093932
  • PatnaikSGuptaKCNovel polyethylenimine-derived nanoparticles for in vivo gene deliveryExpert Opin Drug Deliv20131021522823252504
  • ZhaoYYangRLiuDStarburst low-molecular weight polyethylenimine for efficient gene deliveryJ Biomed Mater Res A201210013414021997931
  • TianHLiFChenJHuangYChenXN-isopropylacrylamide-modified polyethylenimines as effective gene carriersMacromol Biosci2012121680168823129451
  • ZhengMZhongYMengFPengRZhongZLipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfectionMol Pharm201182434244321923163
  • GuoZTianHLinLHydrophobic polyalanine modified hyperbranched polyethylenimine as high efficient pDNA and siRNA carrierMacromol Biosci20141441064114
  • ZhangJWuDXingZN-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cellsColloids Surf B Biointerfaces2015129546225829127
  • LiZZhangLLiQInduction of apoptosis on cancers cells through N-acetyl-L-leucine-modified polyethylenimine-mediated p53 gene deliveryColloids Surf B Biointerfaces201513563063826322477
  • UnKSakai-KatoKOshimaYKawanishiTOkudaHIntracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomesBiomaterials2012338131814122858002
  • LoYLSungKHChiuCCWangLFChemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene deliveryMol Pharm20131066467623281918
  • DutertreSCazalesMQuarantaMPhosphorylation of CDC25B by aurora-A at the centrosome contributes to the G2-M transitionJ Cell Sci20041172523253115128871
  • KhalilIAKogureKAkitaHHarashimaHUptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev200658324516507881
  • ChiuYLHoYCChenYMThe characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosanJ Control Release201014615215920580915
  • WiktorskaMPapiewska-PająkIOkruszekASacewicz-HofmanINiewiarowskaJDNAzyme as an efficient tool to modulate invasiveness of human carcinoma cellsActa Biochim Pol20105726927520725651
  • WangFSaranRLiuJTandem DNAzymes for mRNA cleavage: choice of enzyme, metal ions and the antisense effectBioorg Med Chem Lett2015251460146325769818
  • MarumotoTZhangDSayaHAurora-A – a guardian of polesNat Rev Cancer20055425015630414
  • BauvoisBNew facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progressionBiochim Biophys Acta20121825293622020293